{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T14:15:00Z","timestamp":1778854500674,"version":"3.51.4"},"reference-count":19,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T00:00:00Z","timestamp":1715299200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>We report an unusual constellation of diseases in a 32-year-old woman with neurofibromatosis type 1 (NF1) diagnosed with the recently described precursor entity of malignant peripheral nerve sheath tumor (MPNST), the so-called atypical neurofibromatous neoplasm with unknown biological potential (ANNUBP) and a large symptomatic cervical arteriovenous fistula. An [<jats:sup>18<\/jats:sup>F] 2-Fluoro-2-deoxy-D-glucose PET\/CT (FDG-PET\/CT) was performed to detect and stage a conspicuous symptomatic cervical tumor. The FDG-PET\/CT showed high FDG uptake in one of the multiple known tumorous lesions associated with peripheral nerves. However, no relevant FDP uptake was observed in this affected cervical area. After digital subtraction angiography, the cervical mass turned out to be a widespread arteriovenous fistula of the vertebral artery. This was successfully treated using endovascular embolization. Subsequently, magnet resonance imaging (MRI) of the FDG-positive tumor revealed a well-enhanced homogeneous mass of the sciatic nerve measuring 5.2\u00d72.4\u00d72.8 cm. Microsurgical gross total tumor resection was performed using ultrasound. The final histopathological diagnosis was ANNUBP transformed from neurofibroma. The patient benefited excellently from the surgery; no recurrence or metastasis has been observed since resection. According to imaging, ANNUBP can be characterized as a well-enhanced homogeneous mass on MRI, displaying high uptake on FDG-PET\/CT and hypoechogenic in ultrasound.<\/jats:p>","DOI":"10.3389\/fonc.2024.1391456","type":"journal-article","created":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T04:34:06Z","timestamp":1715315646000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Case report: Atypical neurofibromatous neoplasm with uncertain biological potential of the sciatic nerve and a widespread arteriovenous fistula mimicking a malignant peripheral nerve tumor in a young patient with neurofibromatosis type 1"],"prefix":"10.3389","volume":"14","author":[{"given":"Nadja","family":"Gr\u00fcbel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregor","family":"Antoniadis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralph","family":"K\u00f6nig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian Rainer","family":"Wirtz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juliane","family":"Bremer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrej","family":"Pala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melanie","family":"Reuter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Teresa","family":"Pedro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,5,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-020-01570-8","article-title":"Advancement in research and therapy of NF1 mutant Malignant tumors","volume":"20","author":"Tao","year":"2020","journal-title":"Cancer Cell Int"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddz095","article-title":"Cdkn2a (Arf) loss drives NF1-associated atypical neurofibroma and Malignant transformation","volume":"28","author":"Rhodes","year":"2019","journal-title":"Hum Mol Genet"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/J.HUMPATH.2017.05.010","article-title":"Histopathologic evaluation of atypical neurofibromatous tumors and their transformation into Malignant peripheral nerve sheath tumor in patients with neurofibromatosis 1\u2014a consensus overview","volume":"67","author":"Miettinen","year":"2017","journal-title":"Hum Pathol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)65507-1","article-title":"Malignant transformation of neurofibromas in neurofibromatosis 1 is associated with CDKN2A\/p16 inactivation","volume":"155","author":"Nielsen","year":"1999","journal-title":"Am J Pathol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/MODPATHOL.2015.134","article-title":"Loss of H3K27 trimethylation distinguishes Malignant peripheral nerve sheath tumors from histologic mimics","volume":"29","author":"Schaefer","year":"2016","journal-title":"Modern Pathol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1093\/NEUONC\/NOY013","article-title":"The characteristics of 76 atypical neurofibromas as precursors to neurofibromatosis 1 associated Malignant peripheral nerve sheath tumors","volume":"20","author":"Higham","year":"2018","journal-title":"Neuro Oncol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/J.HUMPATH.2017.05.010","article-title":"Histopathologic evaluation of atypical neurofibromatous tumors and their transformation into Malignant peripheral nerve sheath tumor in patients with neurofibromatosis 1-a consensus overview","volume":"67","author":"Miettinen","year":"2017","journal-title":"Hum Pathol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3390\/CANCERS15041077","article-title":"Malignant peripheral nerve sheath tumors: latest concepts in disease pathogenesis and clinical management","volume":"15","author":"Yao","year":"2023","journal-title":"Cancers (Basel)"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/6162182","article-title":"The role of [ 18 F]FDG-PET\/CT in predicting Malignant transformation of plexiform neurofibromas in neurofibromatosis-1","volume":"2016","author":"Tovmassian","year":"2016","journal-title":"Int J Surg Oncol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1111\/cas.14802","article-title":"Limitations and benefits of FDG-PET\/CT in NF1 patients with nerve sheath tumors: A cross-sectional\/longitudinal study","volume":"112","author":"Nishida","year":"2021","journal-title":"Cancer Sci"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1159\/000526844","article-title":"Atypical Neurofibromatous Neoplasm with Uncertain Biologic Potential in the Posterior Mediastinum of a Young Patient with Neurofibromatosis Type 1: A Case Report Keywords Atypical neurofibromatous neoplasm with uncertain biologic potential \u00b7 Positron emission tomography \u00b7 Magnetic resonance imaging \u00b7 Malignant peripheral nerve sheath tumor \u00b7 Neurofibromatosis type 1","volume":"15","author":"Miyamoto","year":"2022","journal-title":"Case Rep Oncol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.55.2.288\/ASSET\/339019EA-EA1A-40C0-9059-C4B69CAFEAEA\/ASSETS\/GRAPHIC\/G4237F1.JPEG","article-title":"Arteriovenous fistula in neurofibromatosis","volume":"55","author":"Ma","year":"2000","journal-title":"Neurology"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000030952","article-title":"Clinical Case Report Medicine \u00ae Vertebral arteriovenous fistulae (AVF) and vertebral artery aneurysms in neurofibromatosis type 1 A case report and a systematic review","volume":"101","author":"Zhao","year":"2022","journal-title":"Medicine"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1093\/NEUONC\/NOAB106","article-title":"The 2021 WHO classification of tumors of the central nervous system: a summary","volume":"23","author":"Louis","year":"2021","journal-title":"Neuro Oncol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1093\/NEUONC\/NOAD053","article-title":"Atypical neurofibromas reveal distinct epigenetic features with proximity to benign peripheral nerve sheath tumor entities","volume":"25","author":"Kresbach","year":"2023","journal-title":"Neuro Oncol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/nos287","article-title":"Survival meta-analyses for >1800 Malignant peripheral nerve sheath tumor patients with and without neurofibromatosis type 1","volume":"15","author":"Kolberg","year":"2013","journal-title":"Neuro Oncol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-013-3020-x","article-title":"18F-FDG PET\/CT for detection of Malignant peripheral nerve sheath tumours in neurofibromatosis type 1: tumour-to-liver ratio is superior to an SUVmax cut-off","volume":"24","author":"Salamon","year":"2014","journal-title":"Eur Radiol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.38187","article-title":"Soft tissue tumor without neurofibromatosis type 1 with histopathological suspicion of atypical neurofibromatous neoplasm of uncertain biological potential (ANNUBP)","volume":"15","author":"Tsuchie","year":"2023","journal-title":"Cureus."},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/J.WNEU.2021.09.130","article-title":"Diffusion-weighted magnetic resonance imaging improves the accuracy of differentiation of benign from Malignant peripheral nerve sheath tumors","volume":"157","author":"Koike","year":"2022","journal-title":"World Neurosurg"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2024.1391456\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T04:34:08Z","timestamp":1715315648000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2024.1391456\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,10]]},"references-count":19,"alternative-id":["10.3389\/fonc.2024.1391456"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2024.1391456","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,10]]},"article-number":"1391456"}}